• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

剑突下心包切开引流术与经皮心包引流术治疗心脏压塞相关性心包积液的疗效比较

The efficiency of surgical subxiphoid pericardial drainage and percutaneous pericardial drainage in pericardial effusions associated with cardiac tamponade.

作者信息

Petcu C P, Droc I

机构信息

"Carol Davila" University of Medicine, Bucharest, Romania.

出版信息

Chirurgia (Bucur). 2013 Mar-Apr;108(2):226-33.

PMID:23618573
Abstract

OBJECTIVES

The optimal management for pericardial effusions with cardiac tamponade remains controversial. This study compares the results after two commonly performed techniques: subxiphoid surgical pericardial drainage (DPSS) and percutaneous catheter drainage (DPPK).

MATERIAL AND METHODS

We conducted a 5-year retrospective study to analyse the outcome after DPSS and DPPK in patients with non-traumatic pericardial effusions with cardiac tamponade.

OUTCOMES

Patients with non-traumatic cardiac tamponade were treated with DPSS (N=138) and DPPK (N=54). There were no statistical differences between groups regarding: age, drainage volume and duration of drainage. The etiology was malignant in 72 patients and benign in 120 patients. The 2-year survival was statistically non-significant: 55,1% in the surgical group and 44,4% in the percutaneous group, but there was a slight prevalence of malignant diagnosis in the first group (38% versus 35%). The 1-year survival in patients with proved cyto- hystological malignancy was statistically poorer than in patients with malignant diagnosis and with both negative cytology and hystology (7% versus 33%). The 1-year freedom of re-intervention for recurrence of pericardial effusion was statistically better in the surgical group as in the percutaneous one (92.8% versus 79,6%).

CONCLUSIONS

DPSS and DPPK can be both safely performed. DPSS appears to decrease intervention-necessitating recurrence, but it brings a minimal advantage for the malignant diagnosis over cytology alone.

摘要

目的

心包积液合并心脏压塞的最佳治疗方法仍存在争议。本研究比较了两种常用技术的结果:剑突下心包手术引流(DPSS)和经皮导管引流(DPPK)。

材料与方法

我们进行了一项为期5年的回顾性研究,以分析DPSS和DPPK治疗非创伤性心包积液合并心脏压塞患者的结果。

结果

非创伤性心脏压塞患者接受了DPSS(N = 138)和DPPK(N = 54)治疗。两组在年龄、引流量和引流持续时间方面无统计学差异。病因方面,72例为恶性,120例为良性。2年生存率无统计学意义:手术组为55.1%,经皮组为44.4%,但第一组恶性诊断的比例略高(38%对35%)。经细胞组织学证实为恶性的患者1年生存率在统计学上低于恶性诊断但细胞学和组织学均为阴性的患者(7%对33%)。心包积液复发再次干预的1年无复发生存率在手术组统计学上优于经皮组(92.8%对79.6%)。

结论

DPSS和DPPK均可安全实施。DPSS似乎可降低因复发而需要再次干预的情况,但与单纯细胞学检查相比,其在恶性诊断方面优势极小。

相似文献

1
The efficiency of surgical subxiphoid pericardial drainage and percutaneous pericardial drainage in pericardial effusions associated with cardiac tamponade.剑突下心包切开引流术与经皮心包引流术治疗心脏压塞相关性心包积液的疗效比较
Chirurgia (Bucur). 2013 Mar-Apr;108(2):226-33.
2
Subxiphoid pericardial window for pericardial effusive disease.用于心包积液性疾病的心包剑突下开窗术
J Cardiovasc Surg (Torino). 1989 Sep-Oct;30(5):768-73.
3
[Subxiphoid pericardial window drainage in the management of large pericardial effusions].[剑突下心包开窗引流术治疗大量心包积液]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998 Jun;20(3):216-9.
4
Pericardial drainage for pericardial tamponade: surgical management criteria.心包填塞的心包引流:手术管理标准
Acta Biomed Ateneo Parmense. 2001;72(3-4):75-8.
5
Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.恶性肿瘤患者心包积液的初次及二次治疗结果
Mayo Clin Proc. 2000 Mar;75(3):248-53. doi: 10.4065/75.3.248.
6
Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage.心包积液:剑突下心包造口术与经皮导管引流术的比较
Ann Thorac Surg. 1999 Feb;67(2):437-40. doi: 10.1016/s0003-4975(98)01192-8.
7
Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy.回顾性比较恶性肿瘤相关性心包积液行经皮持续引流与外科心包切开术的疗效、诊断价值和并发症。
Am J Cardiol. 2013 Oct 15;112(8):1235-9. doi: 10.1016/j.amjcard.2013.05.066. Epub 2013 Jul 2.
8
Which treatment in pericardial effusion?心包积液应采用哪种治疗方法?
J Cardiovasc Surg (Torino). 2002 Oct;43(5):735-9.
9
Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management.心脏手术后的心包积液:危险因素、患者特征和当代管理。
Ann Thorac Surg. 2010 Jan;89(1):112-8. doi: 10.1016/j.athoracsur.2009.09.026.
10
Subxiphoid pericardial drainage for pericardial tamponade.剑突下心包引流治疗心包填塞
J Thorac Cardiovasc Surg. 1995 Mar;109(3):546-51; discussion 551-2. doi: 10.1016/S0022-5223(95)70287-3.

引用本文的文献

1
Subxiphoid pericardial drainage for gastric tube ulcer penetrating the pericardium after esophagectomy: A case report.剑突下心包引流术治疗食管癌切除术后胃管溃疡穿透心包1例报告
Int J Surg Case Rep. 2024 Feb;115:109260. doi: 10.1016/j.ijscr.2024.109260. Epub 2024 Jan 13.
2
Comparison of the effectiveness of pericardiocentesis and surgical pericardiotomy in the prognosis of patients with blunt traumatic cardiac tamponade: a multicenter study using the Japan Trauma Data Bank.心包穿刺术与外科心包切开术对钝性创伤性心脏压塞患者预后影响的比较:一项使用日本创伤数据库的多中心研究
Acute Med Surg. 2022 Jun 20;9(1):e768. doi: 10.1002/ams2.768. eCollection 2022 Jan-Dec.
3
Effectiveness and outcomes of 2 therapeutic interventions for cardiac tamponade: A retrospective observational study.
两种心脏压塞治疗干预措施的有效性及结果:一项回顾性观察研究。
Medicine (Baltimore). 2020 Jul 17;99(29):e21290. doi: 10.1097/MD.0000000000021290.
4
Pericardial Disease Associated with Malignancy.心包疾病与恶性肿瘤相关。
Curr Cardiol Rep. 2018 Aug 20;20(10):92. doi: 10.1007/s11886-018-1040-5.
5
Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.因心包积液接受经皮心包穿刺术的癌症患者的治疗结果。
J Am Coll Cardiol. 2015 Sep 8;66(10):1119-28. doi: 10.1016/j.jacc.2015.06.1332.